丹洪注射对大鼠心力衰竭的影响,通过代谢学评估
Lin Li1,2,3, Senjie Zhong4, Jiahao Ye4,5
1The Domestic First-class Discipline Construction Project of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Frontiers in medicine
|October 20, 2023
概括
丹洪注射 (DHI) 通过调节关键代谢途径和生物标志物,如PC ((18:3 ((6Z,9Z,12Z) / 24:0) 和L-氨酸,改善心力衰竭 (HF),揭示了其治疗潜力.
科学领域:
- 心血管医学 心血管医学
- 代谢学 代谢学 代谢学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于心血管疾病,心力衰竭 (HF) 呈现出心脏功能受损.
- 丹洪注射 (DHI) 是一种用于治疗高风的传统中医药,但其机制尚不清楚.
- 了解DHI的生物基础对于其在HF中的临床应用至关重要.
研究的目的:
- 在心力衰竭的老鼠模型中阐明丹洪注射 (DHI) 的潜在保护机制.
- 确定DHI治疗影响的关键代谢途径和生物标志物.
- 探索DHI在治疗心力衰竭中的治疗潜力.
主要方法:
- 使用超高性能液态染色学四极飞行时间/质谱法 (UHPLC-QE/MS) 进行血清代谢分析.
- 多变量统计分析,包括主要组件分析 (PCA) 和OPLS-DA.
- 使用MetaboAnalyst和基因和基因组的京都百科全书 (KEGG) 的途径分析.
主要成果:
- 丹洪注射 (DHI) 治疗改善了心力衰竭模型大鼠的心脏形态,功能和新陈代谢.
- 确定了17种差异性代谢物和6种代谢途径.
- PC 18:3 6Z,9Z,12Z) /24:0) 和L-氨被确定为DHI疗效的新生物标志物.
结论:
- 丹洪注射 (DHI) 证明了心力衰竭 (HF) 的治疗潜力.
- DHI有效调节特定的代谢途径和生物标志物.
- 这项研究提供了对DHI在HF管理中的好处的机制性理解.
更多相关视频
07:13A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
6.5K
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
1.4K
相关概念视频
01:29Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
01:30Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9